Most people have the Epstein-Barr (EBV) virus. Sometimes people are unaware of this virus in their body; it settles into immune cells and remains for the duration.
Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of ...
Scientists at Fred Hutch Cancer Center have reported an important advance in the effort to stop Epstein Barr virus (EBV), a ...
Presentation raises questions about EBV timing. Dalia Rotstein, MD, of the University of Toronto, discussed the findings and their implications in an oral presentation at the Amer ...
Study data presented at ACTRIMS 2026 suggests clinical MS onset may precede laboratory-confirmed primary EBV infection in some patients.
Jill A. Hollenbach is in the Department of Neurology, University of California, San Francisco, San Francisco, California 94143, USA, and in the Department of Epidemiology and Biostatistics, University ...
Immune cells (killer T cells) present in the spinal fluid are attacking the Epstein-Barr virus (EBV) in multiple sclerosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results